Statera Biopharma Pink Sheet Forecast - Accumulation Distribution
| STABDelisted Stock | USD 0.04 0.0003 0.82% |
Statera Pink Sheet Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Statera Biopharma stock prices and determine the direction of Statera Biopharma's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Statera Biopharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
Statera |
| Check Statera Biopharma Volatility | Backtest Statera Biopharma | Trend Details |
Statera Biopharma Trading Date Momentum
| On January 10 2023 Statera Biopharma was traded for 0.10 at the closing time. The top price for the day was 0.10 and the lowest listed price was 0.09 . The trading volume for the day was 2.2 M. The trading history from January 10, 2023 was a factor to the next trading day price jump. The trading price change against the next closing price was 11.11% . The trading price change against the current closing price is 55.56% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Statera Biopharma to competition
View Statera Biopharma Related Equities
| Risk & Return | Correlation |
Statera Biopharma Market Strength Events
Market strength indicators help investors to evaluate how Statera Biopharma pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Statera Biopharma shares will generate the highest return on investment. By undertsting and applying Statera Biopharma pink sheet market strength indicators, traders can identify Statera Biopharma entry and exit signals to maximize returns.
Statera Biopharma Risk Indicators
The analysis of Statera Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Statera Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting statera pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 8.22 | |||
| Standard Deviation | 12.04 | |||
| Variance | 145.01 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Statera Pink Sheet
If you are still planning to invest in Statera Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Statera Biopharma's history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |